Champions Oncology, Inc. (CSBR)

Champions Oncology Income Statement

Financials in millions USD. Fiscal year is May - April.

Year	2023	2022	2021	2020	2019
Revenue	53.87	49.11	41.04	32.12	27.07
Revenue Growth (YoY)	9.69%	19.66%	27.76%	18.68%	33.72%
Cost of Revenue	29.53	23.63	21.45	17	14.27
Gross Profit	24.34	25.48	19.59	15.12	12.8
Selling, General & Admin	17.24	15.5	12.03	10.86	7.73
Research & Development	11.55	9.37	7.2	5.85	4.8
Other Operating Expenses	0.81	0	0	0.34	0
Operating Expenses	29.59	24.87	19.23	17.04	12.53
Operating Income	-5.26	0.61	0.37	-1.92	0.27
Other Expense / Income	0.01	0.02	-0.07	0.04	0.04
Pretax Income	-5.27	0.58	0.44	-1.96	0.23
Income Tax	0.07	0.04	0.08	0.13	0.1
Net Income	-5.34	0.55	0.36	-2.09	0.13
Net Income Growth	-	51.38%	-	-	-
Shares Outstanding (Basic)	14	13	13	12	11
Shares Outstanding (Diluted)	14	14	15	12	14
Shares Change	-4.37%	-2.84%	23.05%	-15.98%	28.25%
EPS (Basic)	-0.39	0.04	0.03	-0.18	0.01
EPS (Diluted)	-0.39	0.04	0.02	-0.18	0.01
EPS Growth	-	100.00%	-	-	-
Free Cash Flow	1.1	4.11	-4.96	0.69	1.03
Free Cash Flow Per Share	0.08	0.31	-0.38	0.06	0.09
Gross Margin	45.18%	51.88%	47.74%	47.08%	47.30%
Operating Margin	-9.76%	1.24%	0.89%	-5.98%	1.00%
Profit Margin	-9.90%	1.12%	0.88%	-6.52%	0.47%
Free Cash Flow Margin	2.04%	8.38%	-12.09%	2.13%	3.80%
Effective Tax Rate	-	6.00%	17.16%	-	44.59%
EBITDA	-3.02	2.21	1.62	-1.14	0.84
EBITDA Margin	-5.61%	4.50%	3.95%	-3.54%	3.09%
Depreciation & Amortization	2.25	1.63	1.18	0.83	0.61
EBIT	-5.27	0.58	0.44	-1.96	0.23
EBIT Margin	-9.78%	1.19%	1.06%	-6.11%	0.85%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).